Stockscreener 앱 받기
8.25
1.79%
-0.15
전일 마감가:
$8.40
열려 있는:
$8.28
하루 거래량:
315.02K
Relative Volume:
3.41
시가총액:
$262.73M
수익:
$193.67M
순이익/손실:
$4.82M
주가수익비율:
17.93
EPS:
0.46
순현금흐름:
$15.53M
1주 성능:
+1.35%
1개월 성능:
+4.96%
6개월 성능:
-10.13%
1년 성능:
-21.13%
1일 변동 폭
$8.21
$8.72
1주일 범위
$8.13
$8.72
52주 변동 폭
$7.15
$13.77
Zynex Inc Stock (ZYXI) Company Profile
명칭
Zynex Inc
전화
(800)-495-6670
주소
9655 MAROON CIRCLE, ENGLEWOOD, CO
ZYXI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 9.30 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.72 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1402 | 295.87M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.6475 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.32 | 142.97M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.01 | 52.16M | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-10-16 | 개시 | RBC Capital Mkts | Outperform |
| 2023-01-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-02-28 | 재확인 | B. Riley Securities | Buy |
| 2021-07-16 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2021-03-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-02-26 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-28 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2020-09-14 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-09-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-07-29 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2020-07-20 | 개시 | Piper Sandler | Overweight |
| 2020-07-13 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-07-10 | 재확인 | H.C. Wainwright | Neutral |
| 2020-06-16 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2020-05-19 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-04-01 | 개시 | Northland Capital | Outperform |
| 2019-09-23 | 개시 | H.C. Wainwright | Buy |
모두보기
Zynex Inc 주식(ZYXI)의 최신 뉴스
Electrotherapy System Market Future Business Opportunities - openPR
How to Take Advantage of moves in (ZYXI) - Stock Traders Daily
Zynex partners with VA to expand pain management access By Investing.com - Investing.com Canada
Zynex partners with VA to expand pain management access - Investing.com
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com
Zynex partners with VA to offer pain management solutions for veterans - Proactive Investors
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States (PR Newswire) - Aktiellt
Zynex partners with Veterans Affairs Medical Centers to deliver noninvasive pain relief solutions - Proactive financial news
Zynex, Inc. Sets Second Quarter 2023 Earnings Call - GuruFocus.com
Zynex Announces Completion of Its Laser Pulse Oximetry Trial - The Eastern Progress Online
Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI - Proactive financial news
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters - The Malaysian Reserve
Zynex to Present at the HC Wainwright Global Investment Conference - The Eastern Progress Online
Zynex UCSF Study Results Demonstrate Laser Technology Benefits i - GuruFocus.com
Zynex study highlights precision of laser-based pulse oximeter in reducing racial bias - Proactive Investors USA
ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial - MSN
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters – Company AnnouncementFT.com - Financial Times
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN
Zynex Sets Third Quarter 2024 Earnings Call - Longview News-Journal
Zynex Inc. Achieves $200M Milestone and Sets Ambitious Goals for 2025 - Proactive Investors UK
Non Invasive Pain Management Devices Market Overall Study - openPR
Objective long/short (ZYXI) Report - Stock Traders Daily
Zynex's (ZYXI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
CHIEF FINANCIAL OFFICER Moorhead Daniel J was granted 5,000 shares and covered exercise/tax liability with 4,879 shares, decreasing direct ownership by 42% to 35,561 units (SEC Form 4) - Quantisnow
Zynex stock retains buy rating on FDA progress - Investing.com
Zynex stock retains buy rating on FDA progress By Investing.com - Investing.com Canada
Zynex completes clinical verification trial of pulse oximeter - Yahoo Finance
Muscle Stimulator Market Next Big Thing | Major Giants- Axiobionics, Zynex, NeuroMetrix - openPR
Hotchkis & Wiley Capital Management LLC Raises Holdings in Zynex, Inc. (NASDAQ:ZYXI) - MarketBeat
Zynex completes trial for new pulse oximeter technology By Investing.com - Investing.com Canada
Laser-Based Pulse Oximeter Advances Toward FDA Submission - Sleep Review
Zynex eyes FDA submission for NiCO pulse oximeter following successful verification trial - Proactive Investors Australia
Zynex completes trial for new pulse oximeter technology - Investing.com
Zynex Completes Breakthrough Clinical Trial for Next-Gen Laser Pulse Oximeter at Duke University - StockTitan
Zynex Announces Open Oximetry Project Membership - GuruFocus.com
Zynex CFO Daniel Moorhead sells $80,800 in company stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Daniel Moorhead Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com
Zynex CFO Daniel Moorhead sells $80,800 in company stock - Investing.com
Zynex joins Open Oximetry Project as it advances innovative NiCO pulse oximeter - Proactive Investors Australia
Zynex Inc (ZYXI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Zynex Inc 주식 (ZYXI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 14 '24 |
Sale |
8.09 |
2,000 |
16,180 |
14,603,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 12 '24 |
Sale |
9.24 |
2,000 |
18,480 |
14,607,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 07 '24 |
Sale |
9.17 |
2,000 |
18,340 |
14,613,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 11 '24 |
Sale |
9.09 |
2,000 |
18,180 |
14,609,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 08 '24 |
Sale |
8.77 |
2,000 |
17,540 |
14,611,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 13 '24 |
Sale |
8.37 |
2,000 |
16,740 |
14,605,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 06 '24 |
Sale |
8.82 |
2,000 |
17,640 |
14,615,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 04 '24 |
Sale |
8.67 |
2,000 |
17,340 |
14,619,350 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 05 '24 |
Sale |
8.05 |
2,000 |
16,100 |
14,617,662 |
| MOORHEAD DANIEL J | CHIEF FINANCIAL OFFICER |
Nov 01 '24 |
Sale |
8.59 |
10,000 |
85,900 |
44,878 |
0.23%
16.96%
자본화:
|
볼륨(24시간):